Earnings Call Insights: Achieve Life Sciences (ACHV) Q1 2026 Management View "I'm honored to step into the role of Chief Executive Officer at such an important time." (CEO, President & Director Andrew Goldberg) Goldberg said Achieve is developing cytisinicline for "cessation of...</strong
NeuroOne Medical Technologies press release (NMTC): Q2 GAAP EPS of -$0.25 misses by $0.02. - Product revenue of $2.4M (+71.4% Y/Y) misses by $0.18M. - As of March 31, 2026, the Company had cash and cash equivalents of $2.8 million, compared to $6.6 million as of September
Acumen Pharmaceuticals targets late 2026 for Phase II ALTITUDE-AD trial results and mid-2027 for IND submissions for two EBD candidates. Acumen Pharmaceuticals plans to release top-line data from its Phase II ALTITUDE-AD trial of sabirnetug in late 2026. The company also a
HUYA reports RMB 1.73 billion in Q1 2026 revenue, up 15% year-over-year, driven by game services and advertising expansion. HUYA posted a 15% year-over-year increase in total net revenues to RMB 1.73 billion for Q1 2026. The growth was fueled by strong performance in game-
Analysts focus on Nebius Group’s capex deployment and ARR trends ahead of its May 12 earnings release. Nebius Group (NBIS) is expected to report a first-quarter loss of $0.78 when it releases earnings before market open on May 12. Revenue for the period is projected to rea
Stock futures declined on Tuesday as markets responded to the breakdown of U.S.-Iran negotiations. President Trump deemed Tehran's proposal "totally unacceptable," which kept the Strait of Hormuz in focus and supported Brent oil prices above the $100 mark, following hotter
SPAR Group reaffirms FY 2026 revenue of $143M-$151M SPAR Group has reiterated its full-year 2026 revenue guidance of $143M-$151M. The company is also targeting a gross margin of around 25% over the next 18-24 months. This announcement comes after the company reac
The company forecasts 17%-20% monthly active user growth recovery by Q3 2026 alongside strong monetization trends. Life360 projected 2026 revenue in a range of $650M to $685M during its Q1 2026 earnings call, citing accelerating monetization and a scaled advertising busine
Alico reaffirms adjusted EBITDA guidance near $14M while reporting $52.9M cash at quarter-end for fiscal 2026 Q2. Alico Inc. set a $40 million year-end cash target after reporting $52.9 million in cash at the end of Q2 fiscal 2026. The company posted net income of $11.4 mi
Semiconductor declines drive tech losses while utilities and consumer staples gain amid market caution over demand and supply chain risks. Technology stocks led declines as semiconductor shares faced pressure, with Micron Technology (MU) dropping 6.07% and Intel (INTC) fal
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.